Wegovy also has cardiovascular outcome data from the SELECT trial, which showed a 20% reduction in major cardiovascular events in people with obesity and established cardiovascular disease
15 , 16 , 17 The most recent guidelines and position statements issued in collaboration by the American Diabetes Association and the European Association for the Study of Diabetes, 8 as well as guidelines from the Chinese Diabetes Society (CDS), 7 emphasize an individually tailored choice of glucoselowering treatment for managing T2D
Long-term supplementation has been correlated with improved myocardial mechanical performance, reduction in ventricular arrhythmias and increased exercise tolerance (7) , and higher levels of carnitine were associated with lower risks of cardiovascular events and recurrent stroke after ischemic stroke (63)
These differences matter for people trying to manage weight or type 2 diabetes
10.1016/j.survophthal.2023.07.002
The advisory committee narrowly recommended listing both forms, but FDA's scientific reviewers recommended against it
